'Mad Money' host Jim Cramer takes a closer look at Five Below after the stock reported earnings.

On the Aug. 31 episode of “Mad Money,” Jim Cramer argued that the August rallies in Palantir and Salesforce reflected a combination of improving fundamentals and the unwinding of an aggressive anti-software trade.

Jim Cramer called it both offensive and defensive, but the two halves of the Hugging Face deal are not equally interesting, and the one that actually moves the stock is the one Jensen Huang left out of his press tour talking points.

'Mad Money' host Jim Cramer talks what impacted today's tape.

Jim Cramer just called a stock he says matters more than Nvidia right now, and the pick is not who most AI investors are watching. The reason behind his conviction reveals a strange tension in how the market is pricing the entire AI buildout.

Jim Cramer is flagging an Amgen drug that Wall Street has largely ignored, and he thinks the cardiovascular opportunity behind it could rival the most valuable pharmaceutical market ever created.

'Mad Money' host Jim Cramer weighs in on stocks including: Nuscale, Seneca Foods, IREN, Box, and Nuvation Bio.

Jim Cramer spent the last week of August 2026 arguing with himself about Super Micro Computer (NASDAQ:SMCI | SMCI Price Prediction). On August 25, during his lightning round on Mad Money, a viewer asked about the AI server maker.

On September 1, a caller mentioned that they do not know how to value Caterpillar Inc. (NYSE:CAT) amid the heavy artificial intelligence market hype and asked for a breakdown.

CNBC host Jim Cramer said Meta Platforms Inc. ‘s (NASDAQ: META ) $17 billion child safety settlement will likely have a smaller financial impact than many investors expect, calling it “barely material” to the company’s earnings once spread over a decade.

'Mad Money' host Jim Cramer takes a closer look at Five Below after the stock reported earnings.